Avience Biomedicals Limited is a listed issue, offered in a price band of ₹208 to ₹208 per share, in lots of 1200 shares. Every figure below is taken from the issue's own filings and exchange disclosures.
One lot of 1200 shares at the upper band price of ₹208 is ₹2,49,600 — the smallest retail application this issue accepts.
Lead managers: Fintellectual Corporate Advisors Pvt. Ltd.
As disclosed in the offer document. Figures in ₹ crore unless the filing states otherwise.
| PAT | Assets | Expense | Revenue | Period Ended |
|---|---|---|---|---|
| ₹2.14 | ₹34.65 | ₹21.43 | ₹24.37 | 2024 |
| ₹7.23 | ₹56.52 | ₹36.17 | ₹45.97 | 2025 |
| ₹5.74 | ₹66.07 | ₹34.06 | ₹41.94 | Jan 2026 |
← All current and upcoming IPOs · Open the interactive Avience Biomedicals terminal →
Every Indian IPO in one place — mainboard and SME — from the day dates are announced through subscription, listing and after. Each issue carries its price band, lot size, the minimum a retail applicant needs, subscription by QIB, NII and retail category, the reported grey market premium with the time it was recorded, and the registrar and lead managers handling it.
Every tool reads the same live feed and the same filed statements, so a name you find in one opens in any of the others.
Open to everyone; the per-issue terminal needs a free account. Alphave is NISM-certified, not a SEBI-registered research analyst — nothing here is investment advice or a recommendation to buy or sell any security.